July 02, 2025

FDA Approves Ready-to-Infuse Vancomycin

Tyzavan is the first FDA-approved vancomycin formulation available at room temperature that requires no compounding, thawing, or dilution, enabling faster treatment in time-critical infections like sepsis.

Conexiant

July 02, 2025

Pearse Keane: Power List Perspectives

Our Power Lister winners explore the major trends in their field, and the seismic impact AI and machine learning is having on the profession

The Ophthalmologist

July 02, 2025

Body Fat Percentage Outranks BMI for Mortality

New research shows body fat percentage predicts long-term mortality more accurately than BMI, suggesting a need to revise how body composition is measured in clinical care.

Conexiant

July 02, 2025

Metabolic Syndrome Strongly Linked to Oral Diseases

New research highlights strong associations between metabolic syndrome and several oral diseases—including periodontitis, caries, and peri-implantitis—calling for more longitudinal studies to explore causation and improve patient care.

Conexiant

July 01, 2025

The Promise of Home Monitoring

One recent study found that home OCT could reduce visit frequency by nearly 48% for neovascular AMD patients.

Ophthalmology Management

June 30, 2025

Breakthrough Device Approvals Outpacing Data

Many FDA-authorized breakthrough therapeutic devices may lack robust clinical testing.

Conexiant

June 30, 2025

Sentara Creates Advanced Cardiac Imaging Team

Sentara's robust cardiovascular program continues to grow in expertise and technological improvements. One of the most recent additions is the Advanced Cardiac Imaging Team (ACIT).

Sentara

June 30, 2025

Can Typos Change a Diagnosis?

Large language models used in clinical decision-making may offer different treatment recommendations depending on how a patient writes their message—even when the medical facts remain unchanged.

Conexiant

June 27, 2025

Could Age Predict DVT in Cellulitis?

A 10-year study found that individuals aged 70 and above with lower limb cellulitis had significantly higher odds of developing deep vein thrombosis.

Conexiant